Vortioxetine vs placebo in major depressive disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled, phase 3 trials in Japan
Psychiatry Clin Neurosci
.
2020 May;74(5):330-332.
doi: 10.1111/pcn.13001.
Epub 2020 Apr 4.
Authors
Taro Kishi
1
,
Kenji Sakuma
1
,
Makoto Okuya
1
,
Yuki Matsuda
2
,
Nakao Iwata
1
Affiliations
1
Department of Psychiatry, School of Medicine, Fujita Health University, Toyoake, Japan.
2
Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan.
PMID:
32175646
DOI:
10.1111/pcn.13001
No abstract available
Publication types
Letter
Comment
MeSH terms
Depressive Disorder, Major*
Double-Blind Method
Humans
Japan
Selective Serotonin Reuptake Inhibitors
Vortioxetine*
Substances
Serotonin Uptake Inhibitors
Vortioxetine
Grants and funding
Takeda Pharmaceutical Company Limited/International